Loading...
Trademark Dashboard – UK Trademark Search & ClearanceUK Trademark — IPO
EMNORTEQ
Application UK00004323402 · Registered
Quick Facts
| Application Number | UK00004323402 |
| Status | Registered |
| Owner | ModernaTx, Inc. |
| Filed | 2026-01-13 |
| Registered | 2026-04-10 |
| Renewal Due | 2036-01-13 |
| Type | Individual |
| Feature | Word |
Is this trademark active?
Yes. EMNORTEQ is currently a registered UK trademark, with renewal due on 2036-01-13. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Vaccines for human use.
Timeline
- Filed: 2026-01-13
- First published: 2026-01-30 (Journal 2026/005)
- Registered: 2026-04-10
- Renewal due: 2036-01-13
About This Trademark
'EMNORTEQ' is a registered trademark on the UK IPO register, owned by ModernaTx, Inc.. The application (UK00004323402) was filed on 13 January 2026 and registered on 10 April 2026. The registration is set to expire on 13 January 2036.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
Frequently Asked Questions
Who owns UK trademark UK00004323402 ('EMNORTEQ')?
UK trademark UK00004323402 for the mark 'EMNORTEQ' in Class 5 is recorded on the UK IPO register as owned by ModernaTx, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00004323402 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00004323402 for the mark 'EMNORTEQ' as registered.
Which goods or services does UK trademark UK00004323402 cover?
UK trademark UK00004323402 for the mark 'EMNORTEQ' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Vaccines for human use.
When was UK trademark UK00004323402 filed?
UK trademark UK00004323402 for the mark 'EMNORTEQ' was filed at the UK IPO on 13 January 2026 and registered on 10 April 2026.
When was UK trademark UK00004323402 published?
The UK IPO first published / advertised UK trademark UK00004323402 for the mark 'EMNORTEQ' on 30 January 2026.
When does UK trademark UK00004323402 need to be renewed?
UK trademark UK00004323402 for the mark 'EMNORTEQ' is currently recorded as valid until 13 January 2036, at which point it will need to be renewed with the UK IPO to remain in force.
Cross-Register Filings
Trademarks matching "EMNORTEQ" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| EMNORTEQSame applicant | 99589502 | 630 | 2026-01-12 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.